Advertisement
UK markets closed
  • NIKKEI 225

    40,074.69
    +443.63 (+1.12%)
     
  • HANG SENG

    17,769.14
    +50.53 (+0.29%)
     
  • CRUDE OIL

    82.92
    -0.46 (-0.55%)
     
  • GOLD FUTURES

    2,338.70
    -0.20 (-0.01%)
     
  • DOW

    39,303.63
    +134.11 (+0.34%)
     
  • Bitcoin GBP

    48,900.89
    -934.61 (-1.88%)
     
  • CMC Crypto 200

    1,333.86
    -10.65 (-0.79%)
     
  • NASDAQ Composite

    17,995.06
    +115.76 (+0.65%)
     
  • UK FTSE All Share

    4,429.66
    -21.82 (-0.49%)
     

At AU$2.45, Is It Time To Put PolyNovo Limited (ASX:PNV) On Your Watch List?

While PolyNovo Limited (ASX:PNV) might not have the largest market cap around , it received a lot of attention from a substantial price increase on the ASX over the last few months. The recent jump in the share price has meant that the company is trading at close to its 52-week high. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, what if the stock is still a bargain? Let’s examine PolyNovo’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.

See our latest analysis for PolyNovo

What Is PolyNovo Worth?

According to our valuation model, PolyNovo seems to be fairly priced at around 4.42% above our intrinsic value, which means if you buy PolyNovo today, you’d be paying a relatively fair price for it. And if you believe that the stock is really worth A$2.35, then there isn’t really any room for the share price grow beyond what it’s currently trading. Although, there may be an opportunity to buy in the future. This is because PolyNovo’s beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company’s shares will likely fall by more than the rest of the market, providing a prime buying opportunity.

What kind of growth will PolyNovo generate?

earnings-and-revenue-growth
earnings-and-revenue-growth

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. With profit expected to more than double over the next couple of years, the future seems bright for PolyNovo. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What This Means For You

Are you a shareholder? It seems like the market has already priced in PNV’s positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value?

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping an eye on PNV, now may not be the most optimal time to buy, given it is trading around its fair value. However, the optimistic prospect is encouraging for the company, which means it’s worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

If you want to dive deeper into PolyNovo, you'd also look into what risks it is currently facing. For example, we've discovered 1 warning sign that you should run your eye over to get a better picture of PolyNovo.

If you are no longer interested in PolyNovo, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com